All Relations between Haloperidol and dopamine

Publication Sentence Publish Date Extraction Date Species
T Matsunaga, K Ohara, N Natsukari, M Fujit. Dopamine D2-receptor mRNA level in rat striatum after chronic haloperidol treatment. Neuroscience research. vol 12. issue 3. 1992-03-25. PMID:1664925. dopamine d2-receptor mrna level in rat striatum after chronic haloperidol treatment. 1992-03-25 2023-08-11 rat
T Yamaguchi, Y Kuraishi, M Minami, K Yabuuchi, M Sato. Involvement of central beta-adrenoceptors in the induction of hypothalamic interleukin-1 beta mRNA by methamphetamine. Neuroscience research. vol 12. issue 3. 1992-03-25. PMID:1686311. prazosin (1 and 5 mg/kg) and yohimbine (1 and 5 mg/kg), alpha-blockers and haloperidol (1 mg/kg), a dopamine antagonist, produced partial and little suppression, respectively. 1992-03-25 2023-08-11 rat
R Rivest, C A Marsde. Muscarinic antagonists attenuate the increase in accumbens and striatum dopamine metabolism produced by clozapine but not by haloperidol. British journal of pharmacology. vol 104. issue 1. 1992-03-23. PMID:1786513. muscarinic antagonists attenuate the increase in accumbens and striatum dopamine metabolism produced by clozapine but not by haloperidol. 1992-03-23 2023-08-11 rat
M Ohno, T Yamamoto, S Uek. Analgesic and discriminative stimulus properties of U-62,066E, the selective kappa-opioid receptor agonist, in the rat. Psychopharmacology. vol 106. issue 1. 1992-03-18. PMID:1346721. the dopamine antagonists haloperidol and sulpiride substituted for the u-62,066e stimulus cue that was, however, not attenuated by the dopamine agonist lisuride. 1992-03-18 2023-08-11 rat
K F Swaiman, V L Mache. Effect of ferric nitrilotriacetate on rostral mesencephalic cells. Neurochemical research. vol 16. issue 12. 1992-03-13. PMID:1686065. in addition to morphologic studies, biochemical assays including specific [3h]flunitrazepam (flu) binding, clonazepam (clo)-displaceable [3h]-flu binding, ro5-4864-displaceable [3h]-flu binding, [3h]-flu binding, [3h]dopamine (da) uptake, [3h]haloperidol (hal) binding, [3h]spiperone (sp) binding, glutamine synthetase activity (gs), and protein determinations were performed. 1992-03-13 2023-08-11 Not clear
K A Young, R Zavodny, P B Hick. Subchronic buspirone, mesulergine, and ICS 205-930 lack effects on D1 and D2 dopamine binding in the rat striatum during chronic haloperidol treatment. Journal of neural transmission. General section. vol 86. issue 3. 1992-03-11. PMID:1837997. subchronic buspirone, mesulergine, and ics 205-930 lack effects on d1 and d2 dopamine binding in the rat striatum during chronic haloperidol treatment. 1992-03-11 2023-08-11 rat
M Dragunow, G S Robertson, R L Faull, H A Robertson, K Janse. D2 dopamine receptor antagonists induce fos and related proteins in rat striatal neurons. Neuroscience. vol 37. issue 2. 1992-03-10. PMID:1966822. rats injected with haloperidol, which binds to both d2 dopamine and sigma receptors or the specific d2 dopamine receptor antagonist ym 09151-2, but not the specific d1 dopamine receptor antagonist sch 23390, showed induction of c-fos protein and c-fos-related antigens in striatal neurons. 1992-03-10 2023-08-11 rat
J D Salamone, R E Steinpreis, L D McCullough, P Smith, D Grebel, K Maha. Haloperidol and nucleus accumbens dopamine depletion suppress lever pressing for food but increase free food consumption in a novel food choice procedure. Psychopharmacology. vol 104. issue 4. 1992-03-09. PMID:1780422. haloperidol and nucleus accumbens dopamine depletion suppress lever pressing for food but increase free food consumption in a novel food choice procedure. 1992-03-09 2023-08-11 rat
D L DeHaven-Hudkins, L M Hildebrand, L C Fleissner, S J War. Lack of correlation between sigma binding potency and inhibition of contractions in the mouse vas deferens preparation. European journal of pharmacology. vol 203. issue 3. 1992-03-05. PMID:1663452. the inhibitory effects of r(+)-3-(3-hydroxyphenyl)-n-1-propylpiperidine ((+)3-ppp) or dtg on electrically stimulated twitch contractions were not antagonized by the putative sigma antagonists dtg, haloperidol, rimcazole or bmy-14802, nor by alpha 2-adrenoceptor, dopamine d1, dopamine d2 or opiate antagonists. 1992-03-05 2023-08-11 mouse
R R Guinetdinov, M B Bogdanov, V M Pogorelov, V S Kudrin, K S Rayevsk. Stereoisomers of the atypical neuroleptic carbidine modulate striatal dopamine release in awake rats. Neuropharmacology. vol 30. issue 11. 1992-03-05. PMID:1685561. intracerebral microdialysis was used to monitor extracellular levels of dopamine (da), 3,4-dihydroxyphenylacetic acid and homovanillic acid in awake rats, after intraperitoneal administration of the cis- and trans-isomers (25 mg/kg and 1 mg/kg, respectively) of carbidine, the atypical neuroleptic drug, in comparison with sulpiride (50 mg/kg) and haloperidol (1 mg/kg). 1992-03-05 2023-08-11 rat
M F Suaud-Chagny, J Ponec, F Gono. Presynaptic autoinhibition of the electrically evoked dopamine release studied in the rat olfactory tubercle by in vivo electrochemistry. Neuroscience. vol 45. issue 3. 1992-03-04. PMID:1775239. the dopamine release evoked by burst stimulation (20 s with a mean frequency of 6 hz) was dose-dependently decreased by d,l-apomorphine (25-800 micrograms/kg, s.c.) or by quinpirole (50 micrograms/kg, s.c.) while the opposite effect was observed with haloperidol (12.5 micrograms/kg-0.5 mg/kg, s.c.) or with d,l-sulpiride (2-200 mg/kg, s.c.). 1992-03-04 2023-08-11 rat
M F Suaud-Chagny, J Ponec, F Gono. Presynaptic autoinhibition of the electrically evoked dopamine release studied in the rat olfactory tubercle by in vivo electrochemistry. Neuroscience. vol 45. issue 3. 1992-03-04. PMID:1775239. the increase induced either by haloperidol or by sulpiride was positively related to the stimulation frequency (from 3 to 9 hz) and reached a stable value (+700% of the pre-drug-evoked dopamine release) with higher frequencies (from 9 to 20 hz). 1992-03-04 2023-08-11 rat
M F Suaud-Chagny, J Ponec, F Gono. Presynaptic autoinhibition of the electrically evoked dopamine release studied in the rat olfactory tubercle by in vivo electrochemistry. Neuroscience. vol 45. issue 3. 1992-03-04. PMID:1775239. this increase also depended on the duration of the stimulation: both single-train (10 pulses) or burst stimulations for 20 s, whose frequency inside the trains was in both cases 14 hz, evoked a dopamine release which was minimally affected by sulpiride or haloperidol. 1992-03-04 2023-08-11 rat
M Mavridis, F C Colpaert, M J Milla. Differential modulation of (+)-amphetamine-induced rotation in unilateral substantia nigra-lesioned rats by alpha 1 as compared to alpha 2 agonists and antagonists. Brain research. vol 562. issue 2. 1992-03-03. PMID:1685341. in rats sustaining unilateral 6-hydroxy-dopamine lesions of the substantia nigra (sn), the indirect dopaminergic agonist, (+)-amphetamine (amph), dose-dependently induced robust, ipsilateral rotation: this could be dose-dependently abolished by the dopamine (d2/d1) antagonist, haloperidol. 1992-03-03 2023-08-11 rat
M E del Valle-Soto, J A Vega, B Calzada, L C Hernández, A Pérez-Casa. Study of the rat TSH-producing cells after met-enkephalin treatment: effects of dopamine antagonists. European journal of basic and applied histochemistry. vol 35. issue 2. 1992-02-25. PMID:1768727. the effects of single and repeated doses of met-enkephalin (met-e) on the ultrastructure and tsh-like immunoreactivity (ir) of pituitary tsh-producing cells, and tsh plasma levels in male rats and the influence of pretreatment with a dopamine antagonist, haloperidol, on these, were evaluated. 1992-02-25 2023-08-11 rat
M E del Valle-Soto, J A Vega, B Calzada, L C Hernández, A Pérez-Casa. Study of the rat TSH-producing cells after met-enkephalin treatment: effects of dopamine antagonists. European journal of basic and applied histochemistry. vol 35. issue 2. 1992-02-25. PMID:1768727. no variations were produced by haloperidol alone, but it prevented the decrease of tsh plasma levels stimulated by met-e. our results suggest that met-e plays a role in the release of tsh, and that dopamine is implicated in this process. 1992-02-25 2023-08-11 rat
P Seth, K K Maitra, D K Gangul. Haloperidol on rat phrenic hemidiaphragm. Archives internationales de pharmacodynamie et de therapie. vol 310. 1992-02-21. PMID:1772333. the depression was poorly reversible and was not mediated through dopamine receptors since neither dopamine nor apomorphine could alter the haloperidol blockade. 1992-02-21 2023-08-11 rat
J S Brog, M C Beinfel. Cholecystokinin release from the rat caudate-putamen, cortex and hippocampus is increased by activation of the D1 dopamine receptor. The Journal of pharmacology and experimental therapeutics. vol 260. issue 1. 1992-02-18. PMID:1346163. depletion of endogenous dopamine by pretreatment of animals with alpha-methyl-para-tyrosine decreased potassium-induced release by 45%, and in these animals, haloperidol no longer inhibited release. 1992-02-18 2023-08-11 rat
A A Megens, F H Awouters, T F Meert, K H Schellekens, C J Niemegeers, P A Jansse. Pharmacological profile of the new potent neuroleptic ocaperidone (R 79,598). The Journal of pharmacology and experimental therapeutics. vol 260. issue 1. 1992-02-18. PMID:1370538. ocaperidone inhibited dopamine agonist (apomorphine, amphetamine or cocaine)-induced behavioral effects at low doses (0.014-0.042 mg/kg) and was, thereby, equipotent with haloperidol (0.016-0.024 mg/kg) and 2.0 to 8.3 times more potent than risperidone. 1992-02-18 2023-08-11 Not clear
A A Megens, F H Awouters, T F Meert, K H Schellekens, C J Niemegeers, P A Jansse. Pharmacological profile of the new potent neuroleptic ocaperidone (R 79,598). The Journal of pharmacology and experimental therapeutics. vol 260. issue 1. 1992-02-18. PMID:1370538. ocaperidone completely blocked the dopamine agonist behavior at slightly higher doses (0.064 mg/kg) and was, thereby, more potent and efficacious than haloperidol (0.097-0.13 mg/kg) and risperidone (0.59-1.17 mg/kg). 1992-02-18 2023-08-11 Not clear